Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 17 of 114

  1. Avexitide

    Amylyx Pharmaceuticals EMEA B.V.

    Post Bariatric Hypoglycemia

    phase 3 small molecule active

    1 trial

  2. Axatilimab (INCA034176)

    Incyte

    Chronic Graft-Versus-Host Disease

    phase 3 small molecule active

    1 trial

  3. Azacitidine

    Takeda

    Myelodysplastic Syndrome

    phase 3 small molecule completed

    1 trial

  4. Azacitidine Combined With Venetoclax and ATRA group

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  5. Azathioprine

    The First People's Hospital of Lianyungang

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  6. Azelastine hydrochloride and Fluticasone propionate

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule active

    1 trial

  7. Azeliragon

    vTv Therapeutics

    Alzheimer's Disease

    phase 3 small molecule terminated

    1 trial

  8. Azeliragon 5mg

    vTv Therapeutics

    Alzheimer's Disease

    phase 3 small molecule terminated

    1 trial

  9. Azetukalner

    Xenon Pharmaceuticals

    Major Depressive Disorder

    phase 3 small molecule active

    3 trials

  10. Azetukalner

    Xenon Pharmaceuticals

    Bipolar Disorder

    phase 3 small molecule active

    1 trial

  11. Azetukalner

    Xenon Pharmaceuticals

    Bipolar Depression

    phase 3 small molecule active

    1 trial

  12. Azilsartan

    Takeda

    Pediatric Hypertension

    phase 3 small molecule completed

    2 trials

  13. Azilsartan Medoxomil

    Takeda

    Hypertension

    phase 3 small molecule completed

    7 trials

  14. Azilsartan Medoxomil and amlodipine

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  15. Azilsartan medoxomil and chlorthalidone

    Takeda

    Essential Hypertension

    phase 3 small molecule completed

    4 trials

  16. Azilsartan medoxomil and chlorthalidone

    Takeda

    Safety

    phase 3 small molecule completed

    1 trial

  17. Azilsartan medoxomil and chlorthalidone

    Takeda

    Hypertension

    phase 3 small molecule completed

    2 trials

  18. Azilsartan medoxomil and olmesartan

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  19. Azilsartan medoxomil with or without add-on chlorthalidone

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  20. Azilsartan medoxomil/placebo

    Takeda

    Essential Hypertension

    phase 3 small molecule completed

    1 trial

  21. Azithromycin

    Cardiff Oncology

    Bronchopulmonary Dysplasia

    phase 3 small molecule terminated

    1 trial

  22. Azithromycin plus hydroxychloroquine

    Iterum Therapeutics plc

    Respiratory Tract Infection Viral

    phase 3 small molecule terminated

    1 trial

  23. Azvudine

    Shanghai Henlius Biotech

    SARS-CoV-2 Infection

    phase 3 small molecule active

    1 trial

  24. B/F/TAF

    Gilead Sciences Ireland UC

    HIV-1/HBV Co-Infection

    phase 3 small molecule completed

    1 trial

  25. B/F/TAF (Adult Strength)

    Gilead Sciences Ireland UC

    HIV-1 Infection

    phase 3 small molecule active

    1 trial

  26. B007

    BRIGHT MINDS BIOSCIENCES INC.

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  27. B007

    BRIGHT MINDS BIOSCIENCES INC.

    Primary Membranous Nephropathy

    phase 3 small molecule active

    2 trials

  28. B013+Nab-Paclitaxel

    BRIGHT MINDS BIOSCIENCES INC.

    Triple Negative Breast Cancer (TNBC)

    phase 3 small molecule completed

    1 trial

  29. B7451015

    Pfizer Australia Pty Ltd

    Moderate to severe atopic dermatitis

    phase 3 small molecule active

    1 trial

  30. B7981027

    Pfizer Australia Pty Ltd

    Alopecia areata

    phase 3 small molecule active

    1 trial

  31. B7981028

    Pfizer Australia Pty Ltd

    Alopecia areata

    phase 3 small molecule active

    1 trial

  32. B7981041

    Pfizer Australia Pty Ltd

    NON SEGMENTAL VITILIGO

    phase 3 small molecule active

    1 trial

  33. B7981080

    Pfizer Australia Pty Ltd

    nonsegmental vitiligo

    phase 3 small molecule active

    1 trial

  34. B7981094

    Pfizer Australia Pty Ltd

    Alopecia areata

    phase 3 small molecule active

    1 trial

  35. B9991046

    Pfizer Australia Pty Ltd

    Cancer

    phase 3 small molecule active

    1 trial

  36. BASICstudy

    Wuhan Createrna Science and Technology Co., Ltd

    Chronic cluster headache

    phase 3 small molecule active

    1 trial

  37. BAT5906 injection

    Bio-Thera Solutions

    Diabetic Macular Edema (DME)

    phase 3 small molecule active

    1 trial

  38. BAX 326

    Takeda

    Hemophilia B

    phase 3 mab completed

    1 trial

  39. BAX 326 (Recombinant factor IX)

    Takeda

    Hemophilia B

    phase 3 mab completed

    1 trial

  40. BAX326

    Takeda

    Hemophilia B

    phase 3 mab completed

    1 trial

  41. BAX855

    Baxalta Innovations GmbH

    Hemophilia A

    phase 3 mab completed

    1 trial

  42. BAX855

    Takeda

    Hemophilia A

    phase 3 mab completed

    1 trial

  43. BAY 1841788, TRIPTORELIN

    Ningbo Cancer Hospital

    Patients with localised prostate cancer and high-risk features of relapse (minimum 2 high-risk criteria from National Comprehensive Cancer Network (NCCN) classification)1 and with no detectable metastasis, including no evidence of pelvic lymph node metastasis on next-generation imaging (PSMA PET/CT).

    phase 3 small molecule active

    1 trial

  44. BAY 3427080, BAY 3427080 60 mg capsules placebo

    Bayer AG

    Vasomotor symptoms caused by adjuvant endocrine therapy in women with, or at high risk for developing hormone-receptor positive breast cancer

    phase 3 small molecule active

    1 trial

  45. BAY 59-7939

    Bayer HealthCare AG

    Pulmonary Embolism

    phase 3 small molecule completed

    1 trial

  46. BAY 94-9027/21824

    Bayer AG

    Severe hemophilia A (<1% FVIII:C)

    phase 3 small molecule active

    1 trial

  47. BAY94-9027

    Bayer HealthCare AG

    Hemophilia A

    phase 3 mab completed

    1 trial

  48. BAZOOKA_221

    The George Institute

    Rabies infection/prophylaxis

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.